-
1.COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC 有权
标题翻译: 用于治疗因HDAC的抑制而改善的病症的化合物公开(公告)号:EP2882724B1
公开(公告)日:2017-11-01
申请号:EP13745671.1
申请日:2013-08-07
申请人: IRBM - Science Park S.p.A. , C.N.C.C.S. Scarl Collezione Nazionale Dei Composti Chimici e Centro Screening
发明人: ALTAMURA, Sergio , BRESCIANI, Alberto , BREVEGLIERI, Giulia , FABBRINI, Danilo , GAMBARI, Roberto , HARPER, Steven , LAUFER, Ralph , MONTEAGUDO, Edith , NIZI, Emanuela , PACE, Paola , SUMMA, Vincenzo
IPC分类号: C07D263/32 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , A61K31/421 , A61P35/00 , A61P7/00
CPC分类号: C07D263/32 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/496 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
-
2.COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS THAT ARE AMELIORATED BY INHIBITION OF HDAC 有权
标题翻译: 用以进行化合物治疗是通过抑制HDAC减轻疾病公开(公告)号:EP2882724A1
公开(公告)日:2015-06-17
申请号:EP13745671.1
申请日:2013-08-07
申请人: IRBM - Science Park S.p.A. , C.N.C.C.S. Scarl Collezione Nazionale Dei Composti Chimici e Centro Screening
发明人: ALTAMURA, Sergio , BRESCIANI, Alberto , BREVEGLIERI, Giulia , FABBRINI, Danilo , GAMBARI, Roberto , HARPER, Steven , LAUFER, Ralph , MONTEAGUDO, Edith , NIZI, Emanuela , PACE, Paola , SUMMA, Vincenzo
IPC分类号: C07D263/32 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14 , A61K31/421 , A61P35/00 , A61P7/00
CPC分类号: C07D263/32 , A61K31/421 , A61K31/422 , A61K31/427 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/496 , C07D413/12 , C07D413/14 , C07D417/12 , C07D417/14
摘要: The present invention relates to compounds of formula (I) and (IV), and pharmaceutically acceptable salts, tautomers, stereoisomers thereof, which are inhibitors of histone deacetylase (HDAC). The compounds of the present invention are for usein the treatment of disorders that are ameliorated by inhibition of HDACsuch ascancer and hemoglobinopathieslike β-thalassemia or sickle cell anemia.
摘要翻译: 本发明涉及式(I)和(IV)及其药学上可接受的盐,互变异构体的化合物,其立体异构体,其是组蛋白脱乙酰酶(HDAC)的抑制剂。 本发明的化合物可用于在疾病的治疗中使用并通过抑制HDAC的改善:如癌症和如β-地中海贫血或镰状细胞贫血血红蛋白病。
-